+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2013-12-19Number of Pages: 105

Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Assumptions

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)

2.2 Global Orthobiologics Market, by Products, 2012 (USD Million)

2.3 Global Orthobiologics Market, by Applications, 2012 (USD Million)

 

Chapter 3 Market Overview

3.1 Introduction

      3.1.1 Market Drivers

               3.1.1.1 Rising prevalence of chronic arthritis and rapidly aging world population

               3.1.1.2 Surge in sports injuries

               3.1.1.3 Surge in the number of orthopedic surgeries

               3.1.1.4 Technological advances in bone graft materials to boost market growth

               3.1.1.5 Demand for innovative products to bolster the growth of the market

      3.1.2 Restraints

               3.1.2.1 Lack of Reimbursement

               3.1.2.2 Stringent regulatory requirements to restrain market growth

     3.1.3 Opportunities

               3.1.3.1 Rise in cell based matrices

               3.1.3.2 Emerging markets

3.2 Porter’s Five Force Analysis: Global Orthobiologics Market

      3.2.1 Bargaining Power of Suppliers

      3.2.2 Bargaining Power of Buyers

      3.2.3 Threat of New Entrants

      3.2.4 Threat of Substitutes

      3.2.5 Competitive Rivalry

3.3 Market Attractiveness Analysis of the Global Orthobiologics Market, by Geography

 

Chapter 4 Global Orthobiologics Market, by Product

4.1 Overview

      4.1.1 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)

4.2 Bone Morphogenetic Proteins

      4.2.1 Global Bone Morphogenetic Proteins Product Market, 2011 – 2019 (USD Million)

4.3 Demineralized Bone Matrix (DBM)

      4.3.1 Global Demineralized Bone Matrix Product Market, 2011 – 2019 (USD Million)

4.4 Synthetic Bone Substitutes

      4.4.1 Global Synthetic Bone Substitutes Product Market, 2011 – 2019 (USD Million)

4.5 Viscosupplementation

      4.5.1 Global Viscosupplementation Product Market, 2011 – 2019 (USD Million)

4.6 Allograft

      4.6.1 Global Allografts Product Market, 2011 – 2019 (USD Million)

4.7 Stem Cell Therapy

      4.7.1 Global Stem Cell Therapy Product Market, 2011 – 2019 (USD Million)

4.8 Machined Bones

      4.8.1 Global Machined Bones Product Market, 2011 – 2019 (USD Million)

 

Chapter 5 Global Orthobiologics Market, by Application

5.1 Overview

      5.1.1 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

5.2 Spinal Fusion

      5.2.1 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)

5.3 Trauma

      5.3.1 Global Trauma Application Market, 2011 – 2019 (USD Million)

5.4 Reconstructive surgery

      5.4.1 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)

 

Chapter 6 Global Orthobiologics Market, by Geography

6.1 Overview

      6.1.1 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)

6.2 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)

6.3 North America

      6.3.1 North America Orthobiologics Market, by Product, 2011 – 2019 (USD Million)

      6.3.2 North America Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

6.4 Europe

      6.4.1 Europe Orthobiologics Market, by Product, 2011 – 2019 (USD Million)

      6.4.2 Europe Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

6.5 Asia-Pacific

      6.5.1 Asia-Pacific Orthobiologics Market, by Product, 2011 – 2019 (USD Million)

      6.5.2 Asia-Pacific Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

6.6 RoW

      6.6.1 RoW Orthobiologics Market, by Product, 2011 – 2019 (USD Million)

      6.6.2 RoW Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

 

Chapter 7 Global Orthobiologics Market Share Analysis

7.1 Market Share Analysis by Key Players of Global Orthobiologics Market

      7.1.1 Global Orthobiologics Market Share Analysis, by Key Players, 2012 (%)

 

Chapter 8 Recommendations

8.1 Success strategies

      8.1.1 Rigorous research and development (R&D) initiatives

      8.1.2 Investing in emerging economies

8.2 Barriers to be considered

      8.2.1 Significant Cost of Investment

 

Chapter 9 Company Profiles

9.1 Alphatec Spine, Inc.

      9.1.1 Business Overview

      9.1.2 Financial Overview

      9.1.3 Product Portfolio

      9.1.4 Business Strategies

      9.1.5 Recent Developments

9.2 Bacterin International, Inc.

      9.2.1 Business Overview

      9.2.2 Financial Overview

      9.2.3 Product Portfolio

      9.2.4 Business Strategies

      9.2.5 Recent Developments

9.3 Biomet, Inc.

      9.3.1 Business overview

      9.3.2 Financial Overview

      9.3.3 Product Portfolio

      9.3.4 Business Strategies

9.4 DePuy Synthes, Inc. (A Johnson & Johnson Company)

      9.4.1 Business Overview

      9.4.2 Financial Overview

      9.4.3 Product Portfolio

      9.4.4 Business Strategies

      9.4.5 Recent Developments

9.5 Exactech, Inc.

      9.5.1 Business Overview

      9.5.2 Financial Overview

      9.5.3 Product Portfolio

      9.5.4 Business Strategies

      9.5.5 Recent Developments

9.6 Globus Medical, Inc.

      9.6.1 Business Overview

      9.6.2 Financial Overview

      9.6.3 Product Portfolio

      9.6.4 Business Strategies

      9.6.5 Recent Developments

9.7 Integra LifeSciences Corporation

      9.7.1 Business Overview

      9.7.2 Financial Overview

      9.7.3 Product Portfolio

      9.7.4 Business Strategies

      9.7.5 Recent Developments

9.8 Medtronic, Inc.

      9.8.1 Business Overview

      9.8.2 Financial Overview

      9.8.3 Product Portfolio

      9.8.4 Business Strategies

      9.8.5 Recent Developments

9.9 NuVasive, Inc.

      9.9.1 Business Overview

      9.9.2 Financial Overview

      9.9.3 Product Portfolio

      9.9.4 Business Strategies

      9.9.5 Recent Developments

9.10 Orthofix Holdings, Inc.

      9.10.1 Business Overview

      9.10.2 Financial Overview

      9.10.3 Products Portfolio

      9.10.4 Business Strategies

      9.10.5 Recent Developments

9.11 Regeneration Technologies, Inc.

      9.11.1 Business Overview

      9.11.2 Financial Overview

      9.11.3 Product Portfolio

      9.11.4 Business Strategies

      9.11.5 Recent Developments

9.12 Sanofi

      9.12.1 Business Overview

      9.12.2 Financial Overview

      9.12.3 Product Portfolio

      9.12.4 Business Strategies

      9.12.5 Recent Developments

9.13 Stryker Corporation

      9.13.1 Business Overview

      9.13.2 Financial Overview

      9.13.3 Product Portfolio

      9.13.4 Business Strategies

      9.13.5 Recent Developments

9.14 Wright Medical Technology, Inc.

      9.14.1 Business Overview

      9.14.2 Financial Overview

      9.14.3 Product Portfolio

      9.14.4 Business Strategies

      9.14.5 Recent Developments

9.15 Zimmer Holdings, Inc.

      9.15.1 Business Overview

      9.15.2 Financial Overview

      9.15.3 Product Portfolio

      9.15.4 Business Strategies

      9.15.5 Recent Developments

List of Figures

 

FIG. 1 Orthobiologics: Market Segmentation

FIG. 2 Global Orthobiologics Market, by Products, 2012 (USD Million)

FIG. 3 Global Orthobiologics Market, by Application, 2012 (USD Million)

FIG. 4 Porter’s Five Force Analysis: Global Orthobiologics Market

FIG. 5 Market Attractiveness Analysis: Global Orthobiologics Market, by Geography

FIG. 6 Global Bone Morphogenetic Protein Products, 2011 – 2019 (USD Million)

FIG. 7 Global Demineralized Bone Matrix Products, 2011 – 2019 (USD Million)

FIG. 8 Global Synthetic Bone Substitute Products, 2011 – 2019 (USD Million)

FIG. 9 Global Viscosupplementation Products, 2011 – 2019 (USD Million)

FIG. 10 Global Allograft Products, 2011 – 2019 (USD Million)

FIG. 11 Global Stem Cell Therapy Products, 2011 – 2019 (USD Million)

FIG. 12 Global Machined Bone Products, 2011 – 2019 (USD Million)

FIG. 13 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)

FIG. 14 Global Trauma Application Market, 2011 – 2019 (USD Million)

FIG. 15 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)

FIG. 16 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)

FIG. 17 Global Orthobiologics: Market Share, by Key Players, 2012 (%)

FIG. 18 Alphatec Spine, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 19 Bacterin International Holdings, Inc., Annual Revenue: 2010– 2012 (USD Million)

FIG. 20 Biomet, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 21 Johnson & Johnson, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 22 Exactech, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 23 Globus Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 24 Integra LifeSciences Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 25 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 26 NuVasive, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 27 Orthofix Holdings, Inc., Annual Revenue: 2010-2012 (USD Million)

FIG. 28 Regeneration Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 29 Sanofi, Annual Revenue: 2010 – 2012 (USD Million) (1 Euro= 1.31 USD)

FIG. 30 Stryker Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 31 Wright Medical Technology, Inc.: Annual Revenue 2010 – 2012 (USD Million)

FIG. 32 Zimmer Holdings. Inc, Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

 

TABLE 1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)

TABLE 2 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)

TABLE 3 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

TABLE 4 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)

TABLE 5 North America Orthobiologics Market, by Products, 2011 – 2019 (USD Million)

TABLE 6 North America Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

TABLE 7 Europe Orthobiologics Market, by Products, 2011 – 2019 (USD Million)

TABLE 8 Europe Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

TABLE 9 Asia-Pacific Orthobiologics Market, by Products, 2011 – 2019 (USD Million)

TABLE 10 Asia-Pacific Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

TABLE 11 RoW Orthobiologics Market, by Products, 2011 – 2019 (USD Million)

TABLE 12 RoW Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)


 
 
Back To Top